Towards a field-compatible optical Spectroscopic device for cervical cancer screening in resourcelimited settings: Effects of calibration and pressure

Optics Express

Volumn 19, Issue 19, 2011, Pages 17908-17924

  Chang, Vivide Tuan Chyan ^a   Merisier, Delson ^b   Yu, Bing ^a   Walmer, David K ^b,c   Ramanujam, Nirmala ^a  

^a Duke University   (United States)

^b Family Health Ministries   (Haïti)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORPTION SPECTROSCOPY; DISEASES; ENVIRONMENTAL TECHNOLOGY; PERSONNEL TRAINING; QUALITY CONTROL; REAL TIME SYSTEMS; TISSUE;

ABSORPTION AND SCATTERINGS; DIFFUSE REFLECTANCE SPECTRUM; ENVIRONMENTAL CONDITIONS; LOW-POWER CONSUMPTION; OPTICAL SPECTROSCOPIC; REAL-TIME CORRECTIONS; SCATTERING MEASUREMENTS; SPECTROSCOPIC SYSTEMS;

CALIBRATION;

ACETIC ACID; DIAGNOSTIC AGENT;

ADULT; ARTICLE; CALIBRATION; COMPARATIVE STUDY; EARLY DIAGNOSIS; EVALUATION; FEMALE; HAITI; HUMAN; IMAGE QUALITY; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; MONTE CARLO METHOD; OPTICAL INSTRUMENTATION; PRESSURE; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY; STATISTICS; UTERINE CERVIX TUMOR; VAGINA SMEAR; VALIDATION STUDY;

ACETIC ACID; ADULT; CALIBRATION; EARLY DETECTION OF CANCER; FEMALE; HAITI; HUMANS; MIDDLE AGED; MONTE CARLO METHOD; OPTICAL DEVICES; PHANTOMS, IMAGING; PRESSURE; SENSITIVITY AND SPECIFICITY; SPECTRUM ANALYSIS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 80052735431     PISSN: None     EISSN: 10944087     Source Type: Journal    
DOI: 10.1364/OE.19.017908     Document Type: Article

References (55)

1. PATH. Cervical cancer prevention initiatives at PATH," (PATH). http://www.rho.org/files/PATH-cxca-rep-to-world.pdf, Accessed July 1, 2010.
2. J. Ferlay, F. Bray, P. Pisani, and D. M. Parkin, GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide (IARCPress, Lyon, 2004).
3. A. P. Vizcaino, V. Moreno, F. X. Bosch, N. Muñoz, X. M. Barros-Dios, J. Borras, and D. M. Parkin, "International trends in incidence of cervical cancer: II. squamous-cell carcinoma," Int. J. Cancer 86(3), 429-435 (2000).
4. R. Sankaranarayanan and J. Ferlay, "Worldwide burden of gynaecological cancer: the size of the problem," Best Pract. Res. Clin. Obstet. Gynaecol. 20(2), 207-225 (2006).
5. R. Sankaranarayanan, P. Basu, R. S. Wesley, C. Mahe, N. Keita, C. C. G. Mbalawa, R. Sharma, A. Dolo, S. S. Shastri, M. Nacoulma, M. Nayama, T. Somanathan, E. Lucas, R. Muwonge, L. Frappart, and D. M. Parkin; IARC Multicentre Study Group on Cervical Cancer Early Detection, "Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa," Int. J. Cancer 110(6), 907-913 (2004).
6. S. Arrossi, R. Sankaranarayanan, and D. M. Parkin, "Incidence and mortality of cervical cancer in Latin America," Salud Publica Mex. 45(Suppl 3), S306-S314 (2003).
7. M. E. Soler, L. Gaffikin, and P. D. Blumenthal, "Cervical cancer screening in developing countries," Prim. Care Update Ob Gyns 7(3), 118-123 (2000).
8. S. J. Goldie, L. Gaffikin, J. D. Goldhaber-Fiebert, A. Gordillo-Tobar, C. Levin, C. Mahé, and T. C. Wright; Alliance for Cervical Cancer Prevention Cost Working Group, "Cost-effectiveness of cervical-cancer screening in five developing countries," N. Engl. J. Med. 353(20), 2158-2168 (2005).
9. T. C. Wright, Jr., L. S. Massad, C. J. Dunton, M. Spitzer, E. J. Wilkinson, and D. Solomon; 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference, "2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ," Am. J. Obstet. Gynecol. 197(4), 340-345 (2007).
10. R. Sankaranarayanan, B. M. Nene, S. S. Shastri, K. Jayant, R. Muwonge, A. M. Budukh, S. Hingmire, S. G. Malvi, R. Thorat, A. Kothari, R. Chinoy, R. Kelkar, S. Kane, S. Desai, V. R. Keskar, R. Rajeshwarkar, N. Panse, and K. A. Dinshaw, "HPV screening for cervical cancer in rural India," N. Engl. J. Med. 360(14), 1385-1394 (2009).
11. L. C. Zeferino and S. F. Derchain, "Cervical cancer in the developing world," Best Pract. Res. Clin. Obstet. Gynaecol. 20(3), 339-354 (2006).
12. L. Denny, L. Kuhn, A. Pollack, H. Wainwright, and T. C. Wright, Jr., "Evaluation of alternative methods of cervical cancer screening for resource-poor settings," Cancer 89(4), 826-833 (2000).
13. N. Thekkek and R. Richards-Kortum, "Optical imaging for cervical cancer detection: solutions for a continuing global problem," Nat. Rev. Cancer 8(9), 725-731 (2008).
14. M. F. Mitchell, D. Schottenfeld, G. Tortolero-Luna, S. B. Cantor, and R. Richards-Kortum, "Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis," Obstet. Gynecol. 91(4), 626-631 (1998).
15. A. Dellas, H. Moch, E. Schultheiss, G. Feichter, A. C. Almendral, F. Gudat, and J. Torhorst, "Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations," Gynecol. Oncol. 67(1), 27-33 (1997).
16. J. S. Lee, H. S. Kim, J. J. Jung, M. C. Lee, and C. S. Park, "Angiogenesis, cell proliferation and apoptosis in progression of cervical neoplasia," Anal. Quant. Cytol. Histol. 24(2), 103-113 (2002).
17. S. C. Vieira, B. B. Silva, G. A. Pinto, J. Vassallo, N. G. Moraes, J. O. I. Santana, L. G. Santos, G. A. F. Carvasan, and L. C. Zeferino, "CD34 as a marker for evaluating angiogenesis in cervical cancer," Pathol. Res. Pract. 201(4), 313-318 (2005).
18. T. Collier, M. Guillaud, M. Follen, A. Malpica, and R. Richards-Kortum, "Real-time reflectance confocal microscopy: comparison of two-dimensional images and three-dimensional image stacks for detection of cervical precancer," J. Biomed. Opt. 12(2), 024021-024027 (2007).
19. R. A. Drezek, T. Collier, C. K. Brookner, A. Malpica, R. Lotan, R. R. Richards-Kortum, and M. Follen, "Laser scanning confocal microscopy of cervical tissue before and after application of acetic acid," Am. J. Obstet. Gynecol. 182(5), 1135-1139 (2000).
20. J. R. Mourant, T. M. Powers, T. J. Bocklage, H. M. Greene, M. H. Dorin, A. G. Waxman, M. M. Zsemlye, and H. O. Smith, "In vivo light scattering for the detection of cancerous and precancerous lesions of the cervix," Appl. Opt. 48(10), D26-D35 (2009).
21. D. Arifler, I. Pavlova, A. Gillenwater, and R. Richards-Kortum, "Light scattering from collagen fiber networks: micro-optical properties of normal and neoplastic stroma," Biophys. J. 92(9), 3260-3274 (2007).
22. O. Abulafia and D. M. Sherer, "Angiogenesis in the uterine cervix," Int. J. Gynecol. Cancer 10(5), 349-357 (2000).
23. T. Collier, M. Follen, A. Malpica, and R. Richards-Kortum, "Sources of scattering in cervical tissue: determination of the scattering coefficient by confocal microscopy," Appl. Opt. 44(11), 2072-2081 (2005).
24. O. Brummer, G. Böhmer, B. Hollwitz, P. Flemming, K. U. Petry, and H. Kühnle, "MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation-an immunohistochemical study," Gynecol. Oncol. 84(2), 222-227 (2002).
25. A. Talvensaari, M. Apaja-Sarkkinen, M. Höyhtyä, A. Westerlund, U. Puistola, and T. Turpeenniemi, "Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation, " Gynecol. Oncol. 72(3), 306-311 (1999).
26. R. D. Alvarez, T. C. Wright; Optical Detection Group, "Effective cervical neoplasia detection with a novel optical detection system: a randomized trial," Gynecol. Oncol. 104(2), 281-289 (2007).
27. C. Balas, G. Papoutsoglou, and A. Potirakis, "In vivo molecular imaging of cervical neoplasia using acetic acid as biomarker," IEEE J. Sel. Top. Quantum Electron. 14(1), 29-42 (2008).
28. T. DeSantis, N. Chakhtoura, L. Twiggs, D. Ferris, M. Lashgari, L. Flowers, M. Faupel, S. Bambot, S. Raab, and E. Wilkinson, "Spectroscopic imaging as a triage test for cervical disease: a prospective multicenter clinical trial," J. Low. Genit. Tract Dis. 11(1), 18-24 (2007).
29. J. A. Freeberg, J. L. Benedet, C. MacAulay, L. A. West, and M. Follen, "The performance of fluorescence and reflectance spectroscopy for the in vivo diagnosis of cervical neoplasia; point probe versus multispectral approaches," Gynecol. Oncol. 107(1 Suppl 1), S248-S255 (2007).
30. D. Roblyer, S.-Y. Park, R. Richards-Kortum, I. Adewole, and M. Follen, "Objective screening for cervical cancer in developing nations: lessons from Nigeria," Gynecol. Oncol. 107(1 Suppl 1), S94-S97 (2007).
31. V. T.-C. Chang, S. M. Bean, P. S. Cartwright, and N. Ramanujam, "Visible light optical spectroscopy is sensitive to neovascularization in the dysplastic cervix," J. Biomed. Opt. 15(5), 057006-057009 (2010).
32. G. M. Palmer and N. Ramanujam, "Monte Carlo-based inverse model for calculating tissue optical properties. Part I: Theory and validation on synthetic phantoms," Appl. Opt. 45(5), 1062-1071 (2006).
33. J. E. Bender, K. Vishwanath, L. K. Moore, J. Q. Brown, V. T. Chang, G. M. Palmer, and N. Ramanujam, "A robust Monte Carlo model for the extraction of biological absorption and scattering in vivo," IEEE Trans. Biomed. Eng. 56(4), 960-968 (2009).
34. V. T. C. Chang, P. S. Cartwright, S. M. Bean, G. M. Palmer, R. C. Bentley, and N. Ramanujam, "Quantitative physiology of the precancerous cervix in vivo through optical spectroscopy," Neoplasia 11(4), 325-332 (2009).
35. I. Georgakoudi, E. E. Sheets, M. G. Müller, V. Backman, C. P. Crum, K. Badizadegan, R. R. Dasari, and M. S. Feld, "Trimodal spectroscopy for the detection and characterization of cervical precancers in vivo," Am. J. Obstet. Gynecol. 186(3), 374-382 (2002).
36. J. R. Mourant, T. J. Bocklage, T. M. Powers, H. M. Greene, K. L. Bullock, L. R. Marr-Lyon, M. H. Dorin, A. G. Waxman, M. M. Zsemlye, and H. O. Smith, "In vivo light scattering measurements for detection of precancerous conditions of the cervix," Gynecol. Oncol. 105(2), 439-445 (2007).
37. R. Hornung, T. H. Pham, K. A. Keefe, M. W. Berns, Y. Tadir, and B. J. Tromberg, "Quantitative near-infrared spectroscopy of cervical dysplasia in vivo," Hum. Reprod. 14(11), 2908-2916 (1999).
38. I. Georgakoudi, E. E. Sheets, C. P. Crum, M. G. Mueller, V. Backman, and M. S. Feld, "Trimodal spectroscopy as a tool for detecting cervical squamous intraepithelial lesions in vivo," in Diagnostic Optical Spectroscopy in Biomedicine(SPIE, Munich, Germany, 2001), pp. 1-9.
39. K. Vishwanath, K. Chang, D. Klein, Y. F. Deng, V. Chang, J. E. Phelps, and N. Ramanujam, "Portable, fiber based, diffuse reflectance spectroscopy systems for estimating tissue optical properties," Appl. Spectrosc. 65(2), 206-215 (2011).
40. B. Yu, H. Fu, T. Bydlon, J. E. Bender, and N. Ramanujam, "Diffuse reflectance spectroscopy with a self-calibrating fiber optic probe," Opt. Lett. 33(16), 1783-1785 (2008).
41. B. Yu, H. L. Fu, and N. Ramanujam, "Instrument independent diffuse reflectance spectroscopy," J. Biomed. Opt. 16(1), 011010 (2011).
42. L. Wang, S. L. Jacques, and L. Zheng, "MCML-Monte Carlo modeling of light transport in multi-layered tissues," Comput. Methods Programs Biomed. 47(2), 131-146 (1995).
43. D. C. Walker, B. H. Brown, A. D. Blackett, J. J. Tidy, and R. H. Smallwood, "A study of the morphological parameters of cervical squamous epithelium," Physiol. Meas. 24(1), 121-135 (2003).
44. J. V. Guimarães, A. K. Salge, D. S. Penha, E. F. Murta, J. C. Saldanha, E. C. Castro, M. A. Dos Reis, and V. P. Teixeira, "Thickness of the cervical epithelium of autopsied patients with acquired immunodeficiency syndrome," Ann. Diagn. Pathol. 11(4), 258-261 (2007).
45. K. Vishwanath, W. T. Barry, M. Dewhirst, and N. Ramanujam, "Using optical spectroscopy to longitudinally monitor physiological changes within solide tumors," Neoplasia 11(9), 899-900 (2009).
46. K. Vishwanath, D. Klein, K. Chang, T. Schroeder, M. W. Dewhirst, and N. Ramanujam, "Quantitative optical spectroscopy can identify long-term local tumor control in irradiated murine head and neck xenografts," J. Biomed. Opt. 14(5), 054051 (2009).
47. M. C. Skala, G. M. Palmer, K. M. Vrotsos, A. Gendron-Fitzpatrick, and N. Ramanujam, "Comparison of a physical model and principal component analysis for the diagnosis of epithelial neoplasias in vivo using diffuse reflectance spectroscopy," Opt. Express 15(12), 7863-7875 (2007).
48. T. M. Bydlon, S. A. Kennedy, L. M. Richards, J. Q. Brown, B. Yu, M. K. Junker, J. Gallagher, J. Geradts, L. G. Wilke, and N. Ramanujam, "Performance metrics of an optical spectral imaging system for intra-operative assessment of breast tumor margins," Opt. Express 18(8), 8058-8076 (2010).
49. J. Q. Brown, L. G. Wilke, J. Geradts, S. A. Kennedy, G. M. Palmer, and N. Ramanujam, "Quantitative optical spectroscopy: a robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo," Cancer Res. 69(7), 2919-2926 (2009).
50. S. Kennedy, J. Geradts, T. Bydlon, J. Q. Brown, J. Gallagher, M. Junker, W. Barry, N. Ramanujam, and L. Wilke, "Optical breast cancer margin assessment: an observational study of the effects of tissue heterogeneity on optical contrast," Breast Cancer Res. 12(6), R91 (2010).
51. S. Prahl, "Tabulated Molar Extinction Coefficient for Hemoglobin in Water."
52. S. K. Chang, D. Arifler, R. Drezek, M. Follen, and R. Richards-Kortum, "Analytical model to describe fluorescence spectra of normal and preneoplastic epithelial tissue: comparison with Monte Carlo simulations and clinical measurements," J. Biomed. Opt. 9(3), 511-522 (2004).
53. V. Chang, D. Merisier, B. Yu, D. Walmer, and N. Ramanujam, "Calibration schemes of a field-compatible optical spectroscopic system to quantify neovascular changes in the dysplastic cervix," Proc. SPIE 7891, 78910A (2011).
54. S. Ruderman, A. J. Gomes, V. Stoyneva, J. D. Rogers, A. J. Fought, B. D. Jovanovic, and V. Backman, "Analysis of pressure, angle and temporal effects on tissue optical properties from polarization-gated spectroscopic probe measurements," Biomed. Opt. Express 1(2), 489-499 (2010).
55. R. Reif, M. S. Amorosino, K. W. Calabro, O. A'Amar, S. K. Singh, and I. J. Bigio, "Analysis of changes in reflectance measurements on biological tissues subjected to different probe pressures," J. Biomed. Opt. 13(1), 010502-010503 (2008).